As of 2026-03-21, the Relative Valuation of Novocure Ltd (NVCR) is (63.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.81 USD, the upside of Novocure Ltd based on Relative Valuation is -641.3%.
The range of the Relative Valuation is (56.70) - (64.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 47.4x - 64.5x | 61.5x |
| Forward P/E multiples | 33.1x - 54.2x | 45.3x |
| Fair Price | (56.70) - (64.86) | (63.93) |
| Upside | -580.1% - -649.2% | -641.3% |
| Date | P/E |
| 2026-03-20 | -9.86 |
| 2026-03-19 | -10.15 |
| 2026-03-18 | -10.07 |
| 2026-03-17 | -10.32 |
| 2026-03-16 | -10.34 |
| 2026-03-13 | -10.07 |
| 2026-03-12 | -10.03 |
| 2026-03-11 | -10.54 |
| 2026-03-10 | -10.65 |
| 2026-03-09 | -10.78 |
| 2026-03-06 | -10.89 |
| 2026-03-05 | -11.89 |
| 2026-03-04 | -11.21 |
| 2026-03-03 | -11.11 |
| 2026-03-02 | -11.29 |
| 2026-02-27 | -11.42 |
| 2026-02-26 | -11.49 |
| 2026-02-25 | -12.52 |
| 2026-02-24 | -9.81 |
| 2026-02-23 | -9.17 |
| 2026-02-20 | -9.49 |
| 2026-02-19 | -9.51 |
| 2026-02-18 | -9.52 |
| 2026-02-17 | -9.30 |
| 2026-02-13 | -9.18 |
| 2026-02-12 | -10.47 |
| 2026-02-11 | -8.77 |
| 2026-02-10 | -8.75 |
| 2026-02-09 | -8.38 |
| 2026-02-06 | -8.47 |
| 2026-02-05 | -8.43 |
| 2026-02-04 | -9.66 |
| 2026-02-03 | -9.89 |
| 2026-02-02 | -10.18 |
| 2026-01-30 | -10.36 |
| 2026-01-29 | -10.34 |
| 2026-01-28 | -10.51 |
| 2026-01-27 | -10.90 |
| 2026-01-26 | -11.08 |
| 2026-01-23 | -11.23 |
| 2026-01-22 | -11.85 |
| 2026-01-21 | -11.33 |
| 2026-01-20 | -10.87 |
| 2026-01-16 | -11.39 |
| 2026-01-15 | -11.53 |
| 2026-01-14 | -11.50 |
| 2026-01-13 | -11.40 |
| 2026-01-12 | -11.84 |
| 2026-01-09 | -11.99 |
| 2026-01-08 | -12.42 |